Global Softgel Capsule Market Size To Worth USD 2.30 Billion By 2033 | CAGR of 6.29% [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Catalent, Inc. (CTLT)
Last catalent, inc. earnings: 2/3 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.catalent.com
Company Research
Source: Yahoo! Finance
USD 2.30 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Sirio Pharma Company Limited., Catalent, Inc., EuroCaps Ltd., Guangdong Yichao Biological Co., Ltd., Aenova Group., CAPTEK Softgel International Inc., Thermo Fisher Scientific Inc., EyePoint Pharmaceuticals, Inc., Windzor Pharma Ltd., Lonza Capsules & Health Ingredients., ProCaps Laboratories, LLC., Soft Gel Technologies, Inc., Elnova Pharma., Captek Softgel International Inc., Hunan Er-Kang Pharmaceutical Co., Ltd, and Others key vendors New York, United States , June 13, 2024 (GLOBE NEWSWIRE) -- The Global Softgel Capsule Market Size is to Grow from USD 1.25 Billion in 2023 to USD 2.30 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 6.29% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4489 Gelatin-based soft gel capsules, sometimes called soft elastic capsules, disintegrate more quickly t
Show less
Read more
Impact Snapshot
Event Time:
CTLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTLT alerts
High impacting Catalent, Inc. news events
Weekly update
A roundup of the hottest topics
CTLT
News
- Sarepta cut to Neutral at Citi on risks to valuation [Seeking Alpha]Seeking Alpha
- Actym Therapeutics Expands Management Team with Key Appointments to Build Product Pipeline and Advance Clinical Development Strategies [Yahoo! Finance]Yahoo! Finance
- Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy [Seeking Alpha]Seeking Alpha
- Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project [Fortune]Fortune
- Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
CTLT
Earnings
- 2/9/24 - Miss
CTLT
Sec Filings
- 6/5/24 - Form 4
- 6/4/24 - Form 144
- 5/29/24 - Form 8-K
- CTLT's page on the SEC website